Gratus Capital
3535 Piedmont Rd NE, Building 14-500, Atlanta, Georgia, 30305, United States
Overview
Gratus Private Capital has two funds under management with investments currently in 16 companies across all stages and industry verticals.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Data Integration
- Data Management
- E-Commerce Platforms
- Financial Services
- Network Security
- Robotics
- Secondary Education
- Virtual Reality
Investment portfolio
- Lucid Bots
Participated · Series A · May 2024
Lucid Bots designs, manufactures and supports autonomous exterior cleaning systems including the Sherpa exterior cleaning drone and the Lavo AI autonomous pressure washing robot. It offers Lucid Refresh, a subscription RaaS platform that bundles hardware, Lucid Command software, training, job intelligence and equipment coverage. The company serves customers ranging from independent operators to enterprise accounts such as Disney, Sunbelt Rentals and commercial facilities managers. Lucid manufactures its products domestically and plans to expand its Charlotte, NC manufacturing capacity. It is a member of the NVIDIA Inception Program and is developing AI and autonomy capabilities in partnership with NVIDIA. The company is led by CEO and Founder Andrew Ashur and has raised a total of $34M to date.
- biospatial
Participated · Series A · Mar 2022
biospatial is a healthcare analytics company and EMS data platform that collects and curates electronic Patient Care Reports (ePCRs) from thousands of EMS providers. Headquartered in Durham, North Carolina, the company builds partnerships with state, local, and commercial EMS agencies to assemble a unique prehospital dataset. As of March 2022 the platform has ingested and analyzed over 150 million ePCRs from agencies in over 40 US states and collects over 100,000 new ePCRs daily. biospatial combines these data with additional healthcare sources and proprietary artificial intelligence to provide near real-time actionable insights to health systems, clinical research organizations, the federal government, and life sciences customers. The company’s core mission is to improve healthcare outcomes through data science, and it supports both its EMS data partners and downstream customers with analytics and services. The Series A financing is intended to expand the company’s customer base and capabilities to accelerate growth and impact on outcomes.
Team
No current team members are available.